1-(3-ethyl-phenyl)-ethanol | 54264-96-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-(3-ethyl-phenyl)-ethanol
• 英文别名: (+/-)-1-Hydroxy-1-(3-aethyl-phenyl)-aethan；1-(3-Aethyl-phenyl)-aethanol；1-(3-Ethylphenyl)ethan-1-ol；1-(3-ethylphenyl)ethanol
• CAS: 54264-96-9
• 化学式: C₁₀H₁₄O
• 分子量: 150.221
• InChiKey: YZQJOFFFRWMDSY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  3-乙基苯乙酮 在 copper oxide-chromium oxide 作用下， 130.0 ℃ 、9.81 MPa 条件下， 生成 1-(3-ethyl-phenyl)-ethanol
  参考文献：
  名称：

  Vinyl Aromatic Compounds. I. The Vapor Phase Dehydration of Arylmethylcarbinols

  摘要：

  DOI：

  10.1021/ja01210a059

文献信息

• [EN] THERAPEUTIC COMPOUNDS<br/>[FR] COMPOSÉS THÉRAPEUTIQUES
  申请人：ALLERGAN INC

  公开号：WO2009137411A1

  公开（公告）日：2009-11-12

  Compounds comprising Formula (I) or a pharmaceutically acceptable salt thereof, are disclosed, wherein J1, J2, U1, B, Y, and A are as described in claims 1-16. Methods, compositions, and medicaments related thereto are also disclosed, for treating glaucoma, inflammatory bowel disease and baldness.

  公开了包含式（I）或其药学上可接受的盐的化合物，其中J1、J2、U1、B、Y和A如权利要求1-16所述。还公开了与此相关的治疗青光眼、炎症性肠病和脱发的方法、组合物和药物。
• Benzylic oxidation of aromatics with cerium(IV) triflate; synthetic scope and mechanistic insight
  作者：Kenneth K. Laali、Mark Herbert、Brad Cushnyr、Anand Bhatt、David Terrano

  DOI：10.1039/b008843i

  日期：——

  The synthetic utility of cerium(IV) triflate Ce(OTf)4 as a reagent for benzylic oxidation has been tested for a variety of aromatic compounds. Insight is provided into various factors that govern these oxidations and their progress. It has been shown that the mode of preparation of Ce(OTf)4 and the % H2O present in the sample have a marked influence on oxidation ability. A variety of mono- and dialkylbenzenes

  三氟铈 酸铈（IV）Ce（OTf ）4用作苄基氧化试剂的合成实用程序已针对多种芳族化合物进行了测试。提供了对控制这些氧化及其进展的各种因素的见解。已经表明，样品中存在的Ce（OTf ）4的制备方式 和％H 2 O对氧化能力有显着影响。已经研究了各种单和二烷基苯，卤代烷基苯，双环和三环系统以及烷氧基苯。该方法为室温下由芳族化合物合成芳族酮和醛提供了一种易于执行的一锅法反应，并有可能被更广泛地应用。
• METHOD FOR FRACTIONATING STEREOISOMERIC COMPOUNDS
  申请人：Jakel Christoph

  公开号：US20090030235A1

  公开（公告）日：2009-01-29

  The present invention relates to a method for fractionating stereoisomeric compounds which have at least one alcohol and/or amino group.

  本发明涉及一种用于分离具有至少一种醇和/或氨基团的立体异构化合物的方法。
• Thrombin receptor antagonists
  申请人：——

  公开号：US20040152736A1

  公开（公告）日：2004-08-05

  A series of compounds represented by the structural formulas 1 2 and pharmaceutically acceptable isomers, salts, solvates and polymorphs thereof are disclosed. Also disclosed are pharmaceutical compositions containing said compounds and their use as thrombin receptor antagonists and binders to cannabinoid receptors.

  本文披露了一系列化合物，其结构式表示为12，并且包括其药学上可接受的异构体、盐、溶剂合物和多晶形式。还披露了含有这些化合物的制药组合物，并将其用作凝血酶受体拮抗剂和大麻素受体结合剂。
• Process for the enantioselective preparation of secondary alcohols by lipase-catalyzed solvolysis of the corresponding acetoacetic esters
  申请人：Popp Alfred

  公开号：US20050032182A1

  公开（公告）日：2005-02-10

  Process for the enantioselective preparation of secondary alcohols, wherein a racemic or enantiomerically enriched mixture of acetoacetic esters of chiral secondary alcohols is subjected to enantioselective enzymatic solvolysis in the presence of a nucleophile and a lipase capable of the solvolytic cleavage of an ester group.

  手性二级醇的对映选择性制备过程，其中手性二级醇的乙酰乙酸酯的混合物（消旋或对映富集）在核苷酸和一种能够溶解酯基的脂肪酶存在下，经过对映选择性酶促溶解反应。